IBDQ Stock Overview
iShares Trust - iShares iBonds Dec 2025 Term Corporate ETF is an exchange traded fund launched by BlackRock, Inc.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
iShares Trust - iShares iBonds Dec 2025 Term Corporate ETF Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$24.73 |
52 Week High | US$24.87 |
52 Week Low | US$24.23 |
Beta | 0 |
1 Month Change | -0.081% |
3 Month Change | -0.24% |
1 Year Change | 1.06% |
3 Year Change | -8.34% |
5 Year Change | -0.56% |
Change since IPO | -0.19% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
IBDQ | US Capital Markets | US Market | |
---|---|---|---|
7D | 0.2% | -2.6% | -3.7% |
1Y | 1.1% | 22.7% | 20.5% |
Return vs Industry: IBDQ underperformed the US Capital Markets industry which returned 22.2% over the past year.
Return vs Market: IBDQ underperformed the US Market which returned 20.2% over the past year.
Price Volatility
IBDQ volatility | |
---|---|
IBDQ Average Weekly Movement | 0.2% |
Capital Markets Industry Average Movement | 3.4% |
Market Average Movement | 6.0% |
10% most volatile stocks in US Market | 16.4% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: IBDQ has not had significant price volatility in the past 3 months.
Volatility Over Time: IBDQ's weekly volatility (0%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2015 | n/a | n/a | www.ishares.com/us/products/272346/IBDQ |
iShares Trust - iShares iBonds Dec 2025 Term Corporate ETF is an exchange traded fund launched by BlackRock, Inc. The fund is managed by BlackRock Fund Advisors. It invests in the fixed income markets of developed countries across the globe. The fund invests in U.S. dollar-denominated, investment-grade securities publicly issued by U.S. and non-U.S.
iShares Trust - iShares iBonds Dec 2025 Term Corporate ETF Fundamentals Summary
IBDQ fundamental statistics | |
---|---|
Market cap | US$2.63b |
Earnings (TTM) | US$0 |
Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs IBDQ overvalued?
See Fair Value and valuation analysisEarnings & Revenue
IBDQ income statement (TTM) | |
---|---|
Revenue | US$0 |
Cost of Revenue | US$0 |
Gross Profit | US$0 |
Other Expenses | US$0 |
Earnings | US$0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did IBDQ perform over the long term?
See historical performance and comparison